Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models

被引:16
|
作者
Luis-Ravelo, Diego [1 ]
Anton, Iker [1 ]
Vicent, Silvestre [1 ]
Hernandez, Igor [1 ]
Valencia, Karmele [1 ]
Zandueta, Carolina [1 ]
Martinez-Canarias, Susana [1 ]
Gurpide, Alfonso [2 ]
Lecanda, Fernando [1 ]
机构
[1] Univ Navarra, Div Oncol, Adhes & Metastasis Lab, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain
[2] Univ Navarra, Dept Oncol, Clin Univ Navarra CUN, E-31080 Pamplona, Spain
关键词
Osteolytic; Microenvironment; MMPs; Cachexia; Osteoclast; HORMONE-RELATED PROTEIN; BREAST-CANCER; CELL-LINES; RECEPTOR ACTIVATOR; GENES; ESTABLISHMENT; INTERLEUKIN-8; PATHOGENESIS; EXPRESSION; MUTATIONS;
D O I
10.1007/s10585-011-9409-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer comprises a large variety of histological subtypes with a frequent proclivity to form bone metastasis; a condition associated with dismal prognosis. To identify common mechanisms in the development of osteolytic metastasis, we systematically screened a battery of lung cancer cell lines and developed three models of non-small cell lung cancer (NSCLC) with a common proclivity to form osseous lesions, which represented different histological subtypes. Comparative analysis revealed different incidences and latency times. These differences were correlated with cell-type-specific secretion of osteoclastogenic factors, including macrophage inflammatory protein-1 alpha, interleukin-8 and parathyroid hormone-related protein, some of which were exacerbated in conditions that mimicked tumor-stroma interactions. In addition, a distinct signature of matrix metalloproteinase (MMP) activity derived from reciprocal tumor-stroma interactions was detected for each tumor cell line. Thus, these results suggest subtle differences in the mechanisms of bone colonization for each lung cancer subtype, but share, although each to a different degree, dual MMP and osteoclastogenic activities that are differentially enhanced upon tumor-stromal interactions.
引用
收藏
页码:779 / 791
页数:13
相关论文
共 30 条
  • [21] Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models
    Stanojkovic, Tatjana P.
    Filimonova, Marina
    Grozdanic, Nadja
    Petovic, Slavica
    Shitova, Anna
    Soldatova, Olga
    Filimonov, Alexander
    Vladic, Jelena
    Shegay, Petr
    Kaprin, Andrey
    Ivanov, Sergey
    Nikitovic, Marina
    MOLECULES, 2022, 27 (24):
  • [22] POTENT ANTICANCER ACTIVITY OF PANOBINOSTAT (LBH589) IN SMALL-CELL LUNG CANCER IN BOTH IN VITRO AND IN VIVO TUMOR MODELS
    Atadja, P.
    Shao, W.
    Wang, Y.
    Growney, J. D.
    Cheng, J.
    Kowal, C.
    Feng, Y.
    O'Connor, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50
  • [23] Anti-Tumor Potential of Gymnema sylvestre Saponin Rich Fraction on In Vitro Breast Cancer Cell Lines and In Vivo Tumor-Bearing Mouse Models
    Ghosh, Abhinav Raj
    Alsayari, Abdulrhman
    Habib, Alaa Hamed
    Wahab, Shadma
    Nadig, Abhishek P. R.
    Rafeeq, Misbahuddin M.
    Binothman, Najat
    Aljadani, Majidah
    Al-Dhuayan, Ibtesam S.
    Alaqeel, Nouf K.
    Khalid, Mohammad
    Krishna, Kamsagara Linganna
    ANTIOXIDANTS, 2023, 12 (01)
  • [24] Bioengineered in vitro 3D model of lung cancer tumor microenvironment with tunable extracellular matrix to investigate the pre-metastatic niche formation in distant organs
    Almeida, Vera Lucia
    Abu Shared, Hydar
    Kelly, Graeme
    Kelly, Helena
    O'leary, Cian
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)
  • [25] CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
    Gravina, Giovanni Luca
    Mancini, Andrea
    Muzi, Paola
    Ventura, Luca
    Biordi, Leda
    Ricevuto, Enrico
    Pompili, Simona
    Mattei, Claudia
    Di Cesare, Ernesto
    Jannini, Emmanuele A.
    Festuccia, Claudio
    PROSTATE, 2015, 75 (12): : 1227 - 1246
  • [26] The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo
    Nicole Lavender
    Jinming Yang
    Sheau-Chiann Chen
    Jiqing Sai
    C. Andrew Johnson
    Philip Owens
    Gregory D. Ayers
    Ann Richmond
    BMC Cancer, 17
  • [27] The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo
    Lavender, Nicole
    Yang, Jinming
    Chen, Sheau-Chiann
    Sai, Jiqing
    Johnson, C. Andrew
    Owens, Philip
    Ayers, Gregory D.
    Richmond, Ann
    BMC CANCER, 2017, 17
  • [28] KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism
    Chattopadhyay, Nibedita
    Berger, Allison J.
    Koenig, Erik
    Bannerman, Bret
    Garnsey, James
    Bernard, Hugues
    Hales, Paul
    Lopez, Angel Maldonado
    Yang, Yu
    Donelan, Jill
    Jordan, Kristen
    Tirrell, Stephen
    Stringer, Bradley
    Xia, Cindy
    Hather, Greg
    Galvin, Katherine
    Manfredi, Mark
    Rhodes, Nelson
    Amidon, Ben
    PLOS ONE, 2015, 10 (12):
  • [29] CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models
    Ren, Fupeng
    Zhu, Jingwen
    Li, Kesang
    Cheng, Yiquan
    Zhu, Xiyan
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1903 - 1913
  • [30] Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo
    Chu, Shu-Chen
    Hsieh, Yih-Shou
    Hsu, Li-Sung
    Chen, Kuo-Shuen
    Chiang, Chien-Cheng
    Chen, Pei-Ni
    INTEGRATIVE CANCER THERAPIES, 2014, 13 (03) : 259 - 273